Sort
23,748 grants matching “melanoma”
Structural and Functional Characterization of RhoGEF Regulation Using Nanodiscs to Assemble Membrane-associated Signaling Scaffolds
$391,100Jennifer Nicole Cash · University Of California At Davis · R35 · FY2024 · GM
The B7x pathways in the tumor microenvironment
$391,020Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2022 · CA
The B7x pathways in the tumor microenvironment
$391,020Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2023 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$390,986University Of Pennsylvania · U10 · FY2002 · CA
UCHL5 as a regulator and therapeutic target in metastatic melanoma
$390,885Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Molecular Targeted Radionuclide Therapy to Enhance Tumor Cell Susceptibility and Response to Immune Checkpoint Inhibition
$390,879Zachary Scott Morris · University Of Wisconsin-Madison · P01 · FY2020 · CA
Hedgehog signaling in head and neck cancer stem cells, and its role in resistance
$390,851Antonio Jimeno · University Of Colorado Denver · R01 · FY2014 · CA
Project 2: Spatial Architecture of Tumor-Mediated Immunosuppression
$390,850Garry P Nolan · Stanford University · U54 · FY2017 · CA
Novel Receptor-Targeting Peptides for Melanoma Therapy
$390,755Yubin Miao · University Of Colorado Denver · R01 · FY2021 · CA
Novel Receptor-Targeting Peptides for Melanoma Therapy
$390,754Yubin Miao · University Of Colorado Denver · R01 · FY2020 · CA
Mutant BRAF as a Therapeutic Target for Melanoma
$390,723Dorothee M Herlyn · Wistar Institute · P01 · FY2010 · CA
Molecular Pathophysiology of Thyroid Cell Growth
$390,619James A Fagin · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology
$390,494Thomas Andrew Zangle · University Of Utah · R01 · FY2023 · CA
UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP
$390,453University Of Colorado Denver · U10 · FY2002 · CA
MicroRNA-Based Detection of Barriers to Melanoma Progression
$390,400Robert Laird Judson-Torres · University Of California, San Francisco · DP5 · FY2015 · OD
MicroRNA-Based Detection of Barriers to Melanoma Progression
$390,400Robert Laird Judson-Torres · University Of California, San Francisco · DP5 · FY2016 · OD
Intracerebrally delivered EGFRvIII-targeted CARs for brain tumors
$390,265John H Sampson · Duke University · P50 · FY2018 · CA
PSM Moffitt Cancer Center Partnership
$390,257Jose A Torres-Ruiz · Ponce School Of Medicine · U56 · FY2008 · CA
A mouse model for human gastrointestinal stromal tumor
$390,130Peter Besmer · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
The role of hypothalamic-sympathoneural-adipocyte axis in healthy aging
$390,000Lei Cao · Ohio State University · R56 · FY2019 · AG
DEGRADING A TRANSCRIPTIONAL REGULATOR OF MITOCHONDRIA TO OVERCOME THERAPEUTIC RESISTANCE IN MELANOMA
$390,000Sanford Burnham Prebys Medical Discovery Institute · · FY2022 · Defense Health Agency
Controlled Release of Macromolecules
$390,000Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2016 · EB
Optimizing oncolytic virus therapy for glioblastoma
$390,000Balveen Kaur · University Of Texas Hlth Sci Ctr Houston · R61 · FY2020 · NS
Controlled Release of Macromolecules
$390,000Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2017 · EB
Molecular Basis for p70S6 Kinase and JARID1B Demethylase Activity and Inhibition
$389,972Ronen Marmorstein · Wistar Institute · P01 · FY2011 · CA